Shizuoka, Japan

Hiroshi Magara

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Magara. Retrieved from https://idiyas.com/inventor/hiroshi-magara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Magara: Innovator in Xanthine Derivatives

Introduction

Hiroshi Magara is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on xanthine derivatives. His research has led to the development of compounds with various therapeutic effects.

Latest Patents

Hiroshi Magara holds a patent for a novel xanthine compound, specifically 8-tricycloalkyl xanthine derivatives. This compound exhibits adenosine A1 receptor antagonizing activity, which results in several beneficial effects, including diuretic, renal-protecting, bronchodilatory, cerebral function improving, and anti-dementia effects. The patent highlights the unique structural features of the compound, where R1 and R2 can represent various hydroxy-substituted, oxo-substituted, or unsubstituted lower alkyl groups.

Career Highlights

Hiroshi Magara is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His work has contributed to the company's reputation as a leader in innovative drug development.

Collaborations

Hiroshi has collaborated with notable colleagues, including Takashi Kuwabara and Junichi Shimada. Their combined expertise has furthered research and development in the pharmaceutical sector.

Conclusion

Hiroshi Magara's contributions to the field of xanthine derivatives exemplify the impact of innovative research in pharmaceuticals. His work continues to influence the development of new therapeutic agents that can improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…